To meet the challenge of pediatric therapeutics, unique formulations and improved delivery methods will be essential. We are forecasting rapid growth in this sector, with specialized pediatric delivery products representing more than one-third of all pediatric prescriptions by the end of the decade.

223

The combination of improved particle properties and more efficient inhaler designs is creating new opportunities for dry powder inhalation and expanding the range of active compounds that can be effectively delivered via the lung. We believe dry powder inhalation will become a major factor in the delivery of a number of emerging therapeutics.

118